Kratz Lab - Homepage
In Dr. Kratz’s lab, both the genetic as well as the immunological landscapes of early-stage high-risk tumors are currently being investigated. Using the latest DNA / RNA sequencing and gene expression techniques combined with a bioinformatics-driven systems biology approach, the lab is comparing the different features of low- vs. high-risk early-stage lung cancer in order to gain a better understanding of the genetic nature of high-risk stage I lung cancer. The lab also utilizes cutting-edge immunological profiling techniques to investigate immune responses generated by certain patients that nurture high-risk disease.
Our mission is to put bench side discoveries in the hands of providers in order improve patient outcomes around the world.
However you give – as a former patient, family member or friend, alumnus, or corporate or foundation partner – your gift has profound impact on lives today and on tomorrow’s medicine, pioneered at UCSF.
We have open positions. Join our team of outstanding researchers.